Entyvio 1 Vial 300 mg

Entyvio (vedolizumab) is a prescription medication used to treat adults with moderately to severely active ulcerative colitis (UC) and adults and adolescents aged 6 and older with moderately to severely active Crohn's disease (CD). Entyvio is an immunosuppressant, which works by blocking certain types of white blood cells from entering the intestines, which helps reduce inflammation. Entyvio is given as an intravenous infusion and typically takes about 30 minutes. Common side effects of Entyvio include headache, upper respiratory infections, nausea, and abdominal pain. Talk to your doctor about the risks and benefits of Entyvio to determine if it is right for you.